opdivo nivolumab development history

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
opdivo nivolumab development history	0.17	0.8	7763	29	36
opdivo	0.96	0.9	637	56	6
nivolumab	1.99	0.9	6550	96	9
development	0.41	1	4694	52	11
history	0.93	0.7	59	33	7

Keyword	CPC	PCC	Volume	Score
opdivo nivolumab development history	0.34	0.4	6763	15
new lung cancer drug opdivo nivolumab	0.94	0.3	1674	50
nivolumab opdivo + ipilimumab yervoy	0.58	1	2468	12
nivolumab opdivo and pembrolizumab keytruda	0.37	0.8	8471	48
opdivo fda approval history	0.6	0.1	7128	77
nivolumab fda approval history	0.99	1	2096	2
when was nivolumab approved	1.58	0.3	1305	58
when did opdivo launch	0.68	0.9	7711	55
nivolumab opdivo bristol myers squibb	1.94	0.8	3600	38
when was opdivo first approved	1.16	0.1	1169	31
when was nivolumab fda approved	0.15	0.9	4417	50
nivolumab pd-1	1.57	0.2	771	90
side effects of nivolumab opdivo	0.77	0.8	5322	11
how long has opdivo been in use	1.58	1	2440	25
nivolumab up to date	0.96	0.5	5873	91
when was opdivo approved by fda	0.74	0.7	3974	43
nivolumab anti-pd-1	0.22	0.6	313	97
latest news for medication opdivo	0.38	0.8	3813	18
new lung cancer drug opdivo clinical trials	1.33	0.5	8114	41
fda approval of nivolumab	0.58	0.8	5017	32
nivolumab fda approval date	1.62	1	5463	65
who makes opdivo drug	1.29	1	5096	57
opdivo clinical trial results	0.76	0.2	4885	84